Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials - Session 305 (8:00 a.m.) | |
 | CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study André Lamy, MD, MHSc, on behalf of the CORONARY Study Investigators, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Canada Video interview (English) | Video Interview (French) | Summary slide |
 | ACRIN PA 4005: Multicenter Randomized Controlled Study of a Rapid “Rule Out” Strategy Using CT Coronary Angiogram Versus Traditional Care for Low-Risk ED Patients with Potential Acute Coronary Syndromes Harold Litt, University of Pennsylvania, Philadelphia Presentation slides | Summary slide |
 | Oral Rivaroxaban Alone for Symptomatic Pulmonary Embolism: The EINSTEIN PE Study Harry Roger Buller, Academic Medical Center, Amsterdam, The Netherlands Summary slide |
![acc12_sslides_leon-[Compatibility-Mode]](/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/image/ucm_438697@z_extracted~1/medium.jpg) | Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of the PARTNER Trial Martin Leon for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, N.Y. Summary slide | Video interview |
| Late-Breaking Clinical Trials IV - Session 306 | |
 | Comparison of Bariatric Surgical Procedures and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Patients with Moderate Obesity: 1-year STAMPEDE Trial Results Philip Raymond Schauer, Cleveland Clinic, Cleveland Summary slide | Video interview |
 | A Mendelian Randomized Controlled Trial of Long Term Reduction in Low-Density Lipoprotein Cholesterol Beginning Early in Life Brian Anthony Ference, Wayne State University School of Medicine, Detroit, Mich. Summary slide |
 | A Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, REGN727/SAR236553, in Patients with Primary Hypercholesterolemia (NCT: 01288443) James McKenney, PharmD, Regeneron Pharmaceuticals, Incorporated, Tarrytown, N.Y. Presentation slides | Summary slide | Video interview |
![acc12_sslides_brignole-[Compatibility-Mode]](/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/image/~extract/UCM_438693~1~staticrendition/medium.jpg) | Pacemaker Therapy in Patients with Neurally-mediated Syncope and Documented Asystole Michele Brignole, MD, on the behalf of the ISSUE-3 investigators, Ospedali del Tigullio, Lavagna, Italy Summary slide | Video interview |
